We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NAV market cap is 285.35k. The company's latest EPS is CAD -0.0302 and P/E is 0.00.
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | 0 | -1,000 | -347k | -1.71M |
| Net Income | -49k | -74k | -94k | -2.15M | -1.72M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 181k | 116k | 112k | 931k | 75k |
| Total Liabilities | 20k | 18k | 109k | 844k | 932k |
| Total Equity | 161k | 98k | 3k | 87k | -857k |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -48k | -81k | -10k | -1.78M | -255k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 25k | -88k | N/A | 2.01M | 27k |
| Market Cap | 285.35k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 57.07M |
| Average Volume (1 week) | 810 |
| Average Volume (1 Month) | 633 |
| 52 Week Change | -83.33% |
| 52 Week High | 0.115 |
| 52 Week Low | 0.005 |
| Spread (Intraday) | 0.01 (50%) |
| Company Name | NAVCO Pharmaceuticals Inc |
| Address |
5205 harvester road, unit 1 burlington, ontario L7L 6B5 |
| Website | https://www.navcopharma.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
